PHARMA-ZI
Timeline
5 events since 2017Board
Capital
Filings
End
20182020202220242026
2018
Annual accounts 2017 filed PDFmicro format · 2 days late
Merger: absorbed by DEVANTHINIC PHARMADissolution of the company · Dissolved without liquidation · Cancellation of 100 shares · General meeting of 28-06-20186 points ▸
- General meeting, 28-06-2018
- Accounting effect, 01-01-2018
- DEVANTHINIC PHARMA holds all the shares
- Power of attorney, Anne André
- Power of attorney, Thibaut De Vriese
- Permanent representative, Thibaut De Vriese
- The deed holds 14 more points.
Merger proposal: to be absorbed by DEVANTHINIC PHARMAPermanent representative: Thibaut De Vriese · DEVANTHINIC PHARMA holds all the shares3 points ▸
- Merger, 23-04-2018
- DEVANTHINIC PHARMA holds all the shares
- Permanent representative, Thibaut De Vriese
- The deed holds 3 more points.
2017
New managerDevanthinic Sprl appointed, Tete Kwassigan resigned · Permanent representative: De Vriese Thibaut · General meeting of 30-09-20174 points ▸
- General meeting, 30-09-2017
- Director resignation, Tete Kwassigan (manager)
- Director appointment, Devanthinic Sprl (manager)
- Permanent representative, De Vriese Thibaut
IncorporationFounder: TETE Kwassigan Tsonyuido · Founding capital of €18,600, 100 shares · Appointment: TETE Kwassigan Tsonyuido (manager)5 points ▸
- Incorporation, 28-02-2017
- Founder, TETE Kwassigan Tsonyuido
- Founding capital, €18,600, 100 shares
- General meeting, 28-02-2017
- Director appointment, TETE Kwassigan Tsonyuido (manager)
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
On 3 March 2017 the Belgian Official Gazette published the deed of incorporation of PHARMA-ZI.1 The company has filed annual accounts once, for financial year 2017.2 In 2018 the company was absorbed by merger into DEVANTHINIC PHARMA.3